October 12, 2010 - The Big Hedge Fund Killing in September

Featured Trades: (THE SEPTEMBER HEDGE FUND KILLING)

3) The Big Hedge Fund Killing in September. I was not alone in posting spectacular results in September. Those who foresaw Ben Bernanke's quantitative easing and its implications for all assets posted huge returns for the month, pushing many into positive territory for the first time this year. Jim Simon's $8 billion quant, Renaissance Technologies, jumped by 8%, Paulson & Co.'s $9 billion Advantage Plus fund? raced ahead by 12.4%, and Singapore based Merchant Commodity Fund soared by 14.9%.

After giving up on any hope of a payday this year, performance bonuses are now back on the table. It seems that after a long dry patch, global macro is arising from the dead. The good news for readers of The Diary of the Mad Hedge Fund Trader? October for me is looking just as hot as last month, thanks to positions in gold, silver, copper, rare earths, oil, corn, wheat, and soybeans.

Hedge Funds Are Tuning Up for a Race to Year End

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.